drugset / Trial / NCT02843984

Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy Complications

NCT02843984

Completed 60 enrolled Università degli Studi di Ferrara
RandomizedParallel-groupOpen-labelPrevention

Summary

Objective: To evaluate the influence of vaginal Lactoferrin administration on amniotic fluid concentration of 47 cytokines, chemokines and growth factors.

Timeline

Start
2011-03
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactoferrin Protein / enzyme biologic 300 mg Other

Indications